Research Highlights

The University at Buffalo Center for Advanced Technology in Big Data and Health Sciences (UB CAT) has awarded six life sciences companies a total of $253,000 to support new biomedical technologies.

As public health experts cautiously anticipate how COVID-19 will play out this fall, Michael W. Russell, PhD, professor emeritus of microbiology and immunology, is reiterating that substantial immunity against the SARS-CoV-2 virus will only happen with a vaccine that can be delivered through the nose.

Developing a more effective vaccine for tuberculosis is the goal of research led by Jonathan F. Lovell, PhD, SUNY Empire Innovation Associate Professor of biomedical engineering, that has been funded by the National Institutes of Health.

Three trainees in the Department of Microbiology and Immunology have received fellowships from the American Heart Association (AHA).

A trainee in the doctoral program in biochemistry has been awarded a two-year predoctoral fellowship from the American Heart Association for her research on a fatal neurodegenerative disorder.